The enemy of knowledge is not ignorance, it’s the illusion of knowledge (Stephen Hawking)

It ain’t what you don’t know that gets you into trouble. It’s what you know for sure that just ain’t so (Mark Twain)

Invest with smart knowledge and objective odds

THE DAILY EDGE: 21 FEBRUARY 2020

U.S. Leading Economic Indicators Show Surprising Improvement

The Conference Board’s Composite Index of Leading Economic Indicators strengthened 0.8% during January following an unrevised 0.3% December decline. It was the largest increase since October 2017. (…)

Last month’s strength was paced by large increases in the weekly initial claims for unemployment insurance and the building permits components. The factory orders for nondefense capital goods, stock prices, the yield spread between 10-year Treasuries & Fed Funds, consumer expectations for business/economic conditions, consumer goods orders and the leading credit index also contributed positively to the index. The length of the average workweek had a neutral effect and the ISM new orders index contributed negatively to the index change.

Three-month growth in the leading index improved to 2.5% (AR) following three straight negative readings. The y/y change of 0.9% compared to a 6.5% high in September 2018.

The Index of Coincident Economic Indicators rose 0.1% during January after holding steady in December, revised from 0.1%. The y/y change of 1.1% was the weakest since September 2016. (…) Three-month growth in the coincident index of 1.9% (AR) remained down from 2.3% in August.

The Index of Lagging Economic Indicators held steady during January after an unrevised 0.1% dip in December. (…) Three-month growth in the lagging index fell to 0.7% from 4.2% six months earlier.

The ratio of coincident-to-lagging economic indicators is considered another leading indicator of economic activity. It increased to a four-month high.

Charts from Advisor Perspectives:

Conference Board's LEI

As we can see, the LEI has historically dropped below its six-month moving average anywhere between 2 to 15 months before a recession. The latest reading of this smoothed rate-of-change suggests no near-term recession risk.

Smoothed LEI

Here is a twelve-month smoothed out version, which further eliminates the whipsaws:

FLASH PMIs
USA: Output contracts for the first time since October 2013

Private sector firms across the U.S. signalled a slight decline in business activity in February. The overall contraction was driven by a notable worsening of service sector performance, where output fell for the first time in four years.

Adjusted for seasonal factors, the IHS Markit Flash U.S. Composite PMI Output Index posted 49.6 in February, down from 53.3 Surprised smile in the opening month of 2020. Although only fractional, the decrease in business activity brought to an end a near-four year sequence of expansion following a contraction in service sector output and a slower rise in manufacturing production amid supplier delays following the outbreak of coronavirus.

 image

New orders received by private sector firms fell for the first time since data collection began in October 2009. The fractional decline in new business stemmed from weak client demand across the service sector and the slowest rise in manufacturing new order volumes for nine months. Private sector companies continued to struggle to attract foreign client demand as new export orders fell for the second month running.

Employment continued to increase midway through the first quarter, albeit at the slowest pace in the current four-month sequence of growth. Manufacturers and service providers alike registered a rise in workforce numbers, although the pace of job creation eased in both monitored sectors.

Inflationary pressures softened in February. The rate of increase in cost burdens eased to the slowest since last October amid reports of lower demand for inputs. As a result, private sector companies raised their output charges at the softest pace for three months.

Business confidence strengthened to an eight-month high in February but remained historically subdued as firms highlighted ongoing global uncertainty and the outbreak of coronavirus.

The seasonally adjusted IHS Markit Flash U.S. Services PMI™ Business Activity Index registered 49.4 in February, down from 53.4 in January. The latest data signalled the first decline in business activity for four years and a notable turnaround from the solid output expansion seen in the opening month of the year.

The contraction in output was in part driven by a renewed decrease in new business across the service sector. Although only fractional overall, the rate of decline was the strongest in the series history (since October 2009). New export orders also fell as firms reported greater hesitancy among clients to place orders amid speculation regarding coronavirus.

Pressure on capacity was reduced in February, as the level of outstanding business fell. As a result, services companies increased their workforce numbers at a softer rate. That said, business confidence reached the strongest since last June.

At the same time, input prices rose at the slowest pace in the current five-month sequence of inflation and was only slight overall. In an effort to remain competitive, firms raised their output charges only fractionally.

Goods producers noted only a slight improvement in operating conditions in February, as signalled by a fall in the IHS Markit Flash U.S. Manufacturing Purchasing Managers’ Index (PMI) from 51.9 to 50.8 midway through the first quarter. The improvement in the health of the manufacturing sector was the slowest since last August.

The lower headline index reading was partially driven by slower expansions in production and new orders. The upturn in output was the softest since last July, with firms stating that weak demand conditions and delays in deliveries following the outbreak of the coronavirus in China had dented production growth.

Although output expectations improved and reached a ten-month high, business confidence remained relatively muted as firms suggested uncertainty surrounding the impact of coronavirus had weighed on optimism and could further impact production.

Meanwhile, inflationary pressures remained historically subdued midway through the first quarter amid a slower rise in cost burdens. Firms only raised their charges fractionally as they sought to remain competitive and boost sales.

Chris Williamson, Chief Business Economist at IHS Markit:

With the exception of the government-shutdown of 2013, US business activity contracted for the first time since the global financial crisis in February. Weakness was primarily seen in the service sector, where the first drop in activity for four years was reported, but manufacturing production also ground almost to a halt due to a near-stalling of orders.

Total new orders fell for the first time in over a decade. The deterioration in was in part linked to the coronavirus outbreak, manifesting itself in weakened demand across sectors such as travel and tourism, as well as via falling exports and supply chain disruptions. However, companies also reported increased caution in respect to spending due to worries about a wider economic slowdown and uncertainty ahead of the presidential election later this year.

The survey data are consistent with GDP growth slowing from just above 2% in January to a crawl of just 0.6% in February. However, the February survey also saw a notable upturn in business sentiment about the year ahead, reflecting widespread optimism that the current slowdown will prove short-lived.

Eurozone business bucks virus impact as growth hits six-month high

The eurozone economy grew at its fastest rate in six months during February, according to flash PMI® data. Although remaining weak, the rate of expansion accelerated for a third straight month despite signs of demand being dampened and production being stymied by the coronavirus outbreak.

At 51.6 in February, the ‘flash’ IHS Markit Eurozone Composite PMI rose from 51.3 in January to indicate the largest monthly increase in business activity since last August. Growth was centered on the services sector, where business grew at the joint-fastest rate seen over the past six months. Manufacturing meanwhile remained in decline, although the rate of contraction in output eased to the mildest seen over the past eight months.

image

The overall rate of expansion remained only modest, however, largely due to subdued new business growth. New orders rose at a rate equal to January’s seven-month high, yet the rise was insufficient to prevent backlogs of work continuing to decline slightly, hinting at persistent excess capacity.

Inflows of new business into the service sector grew at a fractionally weaker rate than seen in the prior two months, the slowdown in part linked to travel, tourism and some areas of business reportedly being disrupted by the coronavirus outbreak.

New orders placed at manufacturers meanwhile fell for a seventeenth successive month. More encouragingly, the overall drop in factory orders was the smallest for 15 months as firming demand from domestic customers helped offset a stronger decline in export orders.

A notable development constraining manufacturing in February was a marked lengthening of supplier delivery times, with delays for inputs the most widespread since December 2018, attributed in many cases to supply chain issues arising from the COVID-19 outbreak.

The ongoing relative weakness of new business growth meant employment continued to rise at a weaker pace than seen throughout most of last year, sustaining the softest spell of job creation seen for five years, albeit with the rate of job creation still up on December’s low. Service sector payroll gains slipped to a 13-month low, but job losses in manufacturing eased to the lowest for three months.

The flash February PMI data also showed inflationary pressures cooling slightly. Average input prices rose at a pace slightly weaker than January’s eight-month high, while average selling prices for goods and services rose at the joint-slowest rate for over three years. Inflation trends continued to vary by sector: service sector costs and prices rose but factory costs and charges continued to fall, with average prices charged for goods dropping at the fastest rate for almost four years.

Finally, expectations of output growth over the coming year dipped from January’s 16-month high, though remained well above the average seen in 2019 and up markedly from the low plumbed last August. Sentiment softened in both services and manufacturing.

(…) The flash PMI has climbed to a six-month high, consistent with GDP growing at a quarterly rate approaching 0.2%. (…)

Japan: Private sector output declines at strongest pace since April 2014

Latest PMI data dash any hopes of a first quarter recovery in Japan and significantly raise the prospect of a technical recession in the world’s third largest economy.

Japan’s economy has gone into 2020 still reliant on services and consumer-centred markets to pick up the slack from the industrial sector. However, fourth quarter GDP disconcertingly showed that the sales tax hike and devasting typhoon in October severely dented consumption, and flash data indicate that domestic demand is still yet to fully recover. New business at services companies fell at the strongest rate since June 2016, with survey evidence implying that the coronavirus outbreak has hit tourism particularly hard in Japan, a key source of demand for services. Overall, February flash PMI data stack the odds heavily against Q1 growth, despite Abe’s best efforts to stimulate the economy after the sales tax hike.

image

Daimler warns of “significant adverse effects” of virus outbreak

“Risks for the Daimler Group may not only affect the development of unit sales, but may also lead to significant adverse effects on production, the procurement market and the supply chain,” the Stuttgart-based company said in its annual report bit.ly/2SJHGOi.

It also noted that the epidemic posed a risk for economic growth in China, other Asian countries and worldwide. (…)

Global Stocks Slip on Signs of Coronavirus’s Economic Impact Stocks fell on early signs of the coronavirus outbreak curtailing economic growth in some markets and evidence that the epidemic is claiming more lives outside China.

Investors may be underestimating the impact of the outbreak on U.S. companies’ earnings as economic activity slows in China and tourism takes a hit, Goldman Sachs Group warned. More than 75,000 people have been diagnosed with coronavirus, and over 2,000 have died globally. South Korea reported its first fatality, while two patients in Iran also died and confirmed cases began to climb in Beijing.

Preliminary figures for Japan’s February manufacturing activity meanwhile showed the sharpest contraction in more than seven years, Deutsche Bank said. Data on the country’s services sector fell to the lowest since April 2014 as the spread of coronavirus hurt tourism, according to IHS Markit. (…)

(…) businesses say the recent upheaval is causing them to rethink their supply chains. Outdoor-fireplace maker Blue Rooster Co., which imports cast-metal parts from China and then assembles them in Minnesota, is now looking at bringing nearly 90% of its production in-house. Currently two of its three main suppliers in China are offline. (…)

Source: World Economics

More supply chains problems:

Canadian ports on two coasts congested due to rail blockades Ships have suspended calls at the Port of Halifax and dozens of cargo vessels are sitting at anchor near the Port of Vancouver as freight shipments have been halted across much of the country
China Says No Turning Point; Korea Infections Jump: Virus Update

The coronavirus outbreak accelerated outside China, with South Korea reporting a surge in infections. China adjusted the number of cases for the third time this month, raising more questions over the reliability of the data.

The epidemic in China has been tentatively contained but hasn’t reached a turning point yet, according to China Central Television, which cited a politburo meeting. Infections in China topped 75,000.

South Korea reported 48 more cases, taking the total number to 204. Neighboring Japan is also seeing outbreaks in several unconnected areas. Singapore reported recoveries outpacing new cases. (…)

A BULL CASE?

From David R. Kotok, Chairman and Chief Investment Officer, Cumberland Advisors:

(…) COVID19 has put all central banks on the stimulus track, and the growth of world liquidity is driving stock prices higher and keeping bond yields very low. At Cumberland we are nearly fully invested in our US ETF strategies, and our quantitative strategies are fully invested and positioned offensively. (…)

So add low interest rates to suppressed inflation (temporarily) coupled with slowing worldwide growth, and we get a powerful upward force for stock prices. Our upside target for the S&P 500 Index is now 3600 or higher.

Let’s think of that in the following way. We reduce the 2020 earnings estimate because of coronavirus shocks. We are taking our estimate for the 2020 calendar year down to $165 with a plus or minus range of $4. But we are also lowering the equity risk premium (ERP), which translates into raising the P/E of those earnings. Here’s why.

Older models of ERP calculations would have kept you out of the stock market for some time now and would still keep you out. Why? Because they were derived when both inflation and interest rates were higher. Does a 300-basis-point ERP apply when the running 10-year Treasury yield is around 1.5-2%? It did apply when that yield was 4%. But should it now be reduced?

We think the answer is yes, if one believes the 10-year yield is now likely to hover around 2% or even lower. The coronavirus has pushed out any rise in interest rates and has added a lot of liquidity fuel from central banks. So we believe the ERP must be smaller now.

Consider what it would mean if the ERP were 200 instead of 300 basis points. Apply a 25 running P/E to our earnings estimate. 4% earnings yield minus 200 basis points of ERP is the base case for a 25 p/e.  It is easy to see how the S&P 500 can trade between 3600 and 4000 even as the coronavirus reduces 2020 earnings. Please note that at that S&P 500 level, the yield on the S&P index is about equal to or above the yield on the 10-year Treasury.

So, we’re leaning to full investment in our portfolios. We don’t like a natural disaster that is sickening many and killing folks every day. We think the spread of the virus will continue. We’ve seen credible estimates as high as an eventual 4-5 million cases and a baseline 2% to 4% fatalities rate worldwide.

But the investment outlook now is for a massive central bank liquidity response, and that means higher multiples for stock markets around the world.

Of course, things could change at any time. The same is true for our managed portfolios.

FYI, a 25 P/E, or a 4% earnings yield (red line below), has very rarely been seen since 1927 and never proved to be in a buy-low environment, to say the least.

image

True, interest rates have also rarely been so low, but when they were nearly as low as currently, the earnings yield, and the ERP, were much higher. Not to say we cannot see 3600, 4000 even, but I would not say these levels are “easy to see”.

Also consider that the correlation between the Earning Yield and 10Y Treasury yields is 20.3% since 1927. BTW, the correlation between the S&P 500 price and trailing EPS is 98.2%. I wonder what “an eventual 4-5 million cases and a baseline 2% to 4% fatalities rate worldwide” would do to economies, earnings and investor confidence. Not to mention what an ever rising USD will do to foreign earnings of S&P 500 companies.

fredgraph (62)
EARNINGS WATCH

We now have 437 reports in, a 70% beat rate and a +5.0% surprise factor.

Q4 earnings are now expected up 3.2% vs –0.3% on Jan. 1. Revenues are up 5.1% vs +4.1% on Jan. 1.

Q1’20 earnings are seen up 3.2%, much slower than the +6.3% of Jan. 1. Q2 forecasts are also trimmed, from +7.2% to +6.0%. Still, full year earnings are seen up 7.7% (vs +9.7% on Jan. 1), a sharp acceleration from +2.0% in 2019.

Pre-announcements remain generally positive compared to Q1’19 and Q4’19 but the last few days were mainly on the negative side…

Trailing EPS are now $164.60. At 3338, the Rule of 20 P/E is 22.55.

Mom and Pop Are On Epic Stock Buying Spree Fueled by Free Trades Small investors are back in a big way.

(…) While it’s tough to know what’s causing what — bull markets are fueled by new converts but also lure them — trading volume at online and discount brokers has exploded. TD Ameritrade Holding Corp., which started offering free trading in October, has seen million-trade days multiplying at a record pace.

Discount brokerages' trading volume explode

(…) “I’ll invest smaller amounts. Before I never really invested anything less than $1,000, $500 minimum,” he said in a phone interview. “Now if I have enough to buy an extra share, I’ll do it. I’ll do like $300.” (…)

“The fact that we have been in a bull market for a long time, people are just optimistic. Things are going up and they continue to go up.” (…)

“There’s sometimes no fundamental reason for it. It just is based on perception — a perception based on narratives that run only an inch deep,” he said in note. “Let’s see how much longer it persists. This kind of activity often unwinds much faster than the wind up.”

Bob Farrell’s Rule #5: “The public buys the most at the top and the least at the bottom”

THE DAILY EDGE: 20 FEBRUARY 2020

U.S. Housing Starts Give Back Some of December Gains in January

Housing starts fell 3.6% m/m (+21.4% y/y) in January to 1.567 million units at an annual rate, giving back some of the outsized weather-aided 17.7% m/m jump in December (1.626 million units), which was revised up from a 16.9% m/m gain (1.608 million units). Still, the decline was smaller than had been anticipated by the Action Economics Forecast Survey, which looked for a decline in January to 1.420 million units.

The January retreat in total starts was due completely to weaker single-family starts, which fell 5.9% m/m (+4.6% y/y) to 1.010 million units. Multi-family starts in January added to their marked 25.4% m/m December surge by edging up 0.7% m/m (+71.4% y/y) to 557,000 units. Multi-family starts are now at their highest level since December 1986. Residential investment in the national accounts rose in both Q3 and Q4; January housing starts point to a robust 2020 Q1 as starts in January were 8.1% above the Q4 average.

Building permits were stronger than expected in January, rising 9.2% m/m (17.9% y/y) to 1.551 million units after having fallen 3.7% m/m in December. The January reading was the highest since March 2007. The issuance of permits is not nearly as affected by weather as are starts. Permits to build single-family homes rose 6.4% m/m (20.2% y/y) to 987,000 while multi-family permits jumped 14.6% m/m (13.9% y/y) to 564,000.

By region, housing starts jumped up 31.9% m/m to 178,000 units in the Northeast and edged up 1.2% m/m to 431,000 in the West. In contrast, starts slumped 25.9% m/m to 180,000 in the Midwest and fell 5.4% m/m to 778,000 in the South.

image

Fed Minutes Show Comfort With Economy, Rate Stance Most officials were more confident that inflation would gradually return to central bank’s 2% target

Officials at the Fed’s Jan. 28-29 policy meeting mostly “saw the distribution of risks to the outlook for economic activity as more favorable than at the previous meeting, although a number of downside risks remained prominent,” according to minutes released Wednesday. (…)

The minutes referred eight times to the coronavirus outbreak. Officials agreed the potential for disruptions from the virus “warranted close watching,” the minutes said. (…)

“There’s no way to be confident about anyone’s assessment, and there are a range of assessments,” he [Powell] said.

China serves as the hub of global supply chains for numerous products, including cars and computer chips. Beijing has imposed quarantines that have idled factories, while air travel to the country has been curtailed. (…)

Separately, the manager of the Fed’s open-market operations outlined a proposal to phase out two-week loans backed by government securities, called repurchase agreements, or repo, after April. By that point, officials expect the Fed will have sufficiently rebuilt reserve balances in the banking system to $1.5 trillion. (…)

The Fed’s market-operations manager indicated the central bank could slow its $60 billion-per-month pace of Treasury bill purchases in the second quarter. The minutes said most Fed officials were comfortable with this proposal.

China banks cut rate to prop up coronavirus-hit economy S&P warns of $1.1tn surge in bad loans and annual economic growth as low as 4.4%

Goldman Sachs:

The imposition of travel restrictions and activity controls by the Chinese government as a result of the Covid-19 outbreak adds pressure to activity levels in China, with our China economics team revising down Q1 growth to 4.0% and 2020 full-year growth to 5.5%. (…) recent indicators suggest the ramping up in industrial production post Chinese New Year has been slower than expected. (…)

We do see slower growth having a negative impact on overall credit quality, with our China banks team recently raising their implied NPL ratio within the China banking sector to 8.1% from their earlier estimate of 5.4%. So the weaker economic outlook should add to the amount of potential stressed credit in China. However, this is partly offset by a number of policy easing measures. In particular, a recent joint statement from several departments introduced a series of measures to support the financial system. These include a pledge from the central bank to ensure sufficient liquidity is supplied, and that support will be provided to enterprises affected by Covid-19, including urging financial institutions to extend maturity or rollover loans coming due for borrowers in difficulties. To us, this is a clear sign of policymakers emphasizing the maintenance of financial stability given the near-term challenges to the economy. (…)

In addition to a deeper and more prolonged slowdown in growth, another key risk is an extended downturn in the property sector, with sharper price cuts and a slowdown in construction activities. (…)

Virus Update
  • China death toll rises to 2,118, with cases at 74,576
  • Hubei adds 108 deaths, new cases up by 349; 1,209 discharged
  • Investor anxiety rises as virus spreads outside China

The Hubei province reported a sharp drop in new cases after another change in the way China diagnoses infections, raising questions over the reliability of the data.

  • Hubei Asks Firms Not to Resume Work Before March 11 Producers of drugs, medical equipment and protective items are not subject to the requirement, according to a statement from the Hubei provincial government.

(…) In mainland China, manufacturers are grappling with a logistical nightmare as many of the workers they depend on cannot return to work, hindered by travel and quarantine restrictions. The restrictions, which differ by province, city and local district, have also made it difficult to transport goods. (…)

The company, formally called Hon Hai Precision Industry Co Ltd, hopes to have production levels in China at half of normal levels by the end of February, a source with direct knowledge of the matter told Reuters last week. (…)

Coronavirus outbreak helps lawmakers make case on drug shortage bills Concerns raised over China’s place in the drug supply chain

The coronavirus outbreak is prompting fears of drug shortages in the United States because of how deeply the pharmaceutical supply chain relies on China. For lawmakers who were already working on bills to address shortages and bring more drug manufacturing back to the U.S., the epidemic is helping them prove their point. (…)

“We have to figure out a way to bring manufacturing of pharmaceutical drugs and generics back to the United States,” Rep. Anna G. Eshoo, D-Calif., told CQ Roll Call’s CQ on Congress podcast last week. “Now, it’s one thing if China makes T-shirts and sportswear and shoes and whatever, but we cannot be dependent on a foreign source, especially a country that is not exactly a 100 percent ally.” (…)

Many finished branded drugs are made in the U.S. But more commonly used generic products are mostly made in China and India, and the raw ingredients needed for them are predominantly made in China, according to the U.S.-China Economic and Security Review Commission.

That raises fear of a supply disruption if China’s government ever wanted to play geopolitical hardball, or because of other circumstances outside of its control — such as a massive outbreak. (…)

Former Food and Drug Administration Commissioner Scott Gottlieb told senators at a Homeland Security and Governmental Affairs hearing last week that China supplies the raw ingredients for many generic anti-infective drugs made in India — a class of products that includes antibiotics and antiviral medications, both of which could actually play a role in treating coronavirus patients. 

The products in shortage typically have in common one thing: They’re cheap. Manufacturers have small profit margins, which means they make money on volume. That leads to industry consolidation and fewer manufacturers, so if something happens to one of them, there are fewer companies to fill the void. (…)

Reuters:

Historically, the FDA and drugmakers have turned to alternate suppliers to help make up shortfalls, but in this case that may be hard to do. That is because China is considered the largest producer of the ingredients drugmakers everywhere require to make their products. Many of those APIs are for generic drugs, and generic drugs make up nearly 90% of the U.S. drug supply.

In India, which gets two-thirds of its APIs from China, the government determined drugmakers have about two-months supply on hand, the Indian Express reports. That is particularly important to the U.S. since the FDA estimates that India accounts for 40% of the U.S. generics. 

India’s Business Today:

Indian pharma companies procure nearly 70 per cent of the active pharmaceutical ingredients for their medicines from China. This is largely for drugs like antibiotics – crucial among them being penicillin G (and other products based on it such as amoxicillin and ampicillin), tetracycline – and for vitamins such as vitamin C and D. All of these are based on drug ingredients made using the fermentation-based process, an area where China has achieved global dominance. (…)

[On Feb. 17] Business Today reported that the government could soon ban around 12 essential medicines – mainly antibiotics, vitamins and hormones – to ensure that there is no shortage of essential drugs in wake of the coronavirus outbreak in Hubei province in China. The government is mulling the ban as the Chinese government continues to impose a lockdown in Hubei as it is the epicentre of the coronavirus epidemic. (…)

Sure looks like the trade war and this virus episode will boost the “reshoring” theme. Ask the automotive industry about it.

Energy Companies Face Looming Debt Burden U.S. oil-and-gas companies need cash, but it won’t come at a cheap price.

Explorers and producers have more than $85 billion of debt maturing over the next four years. Those with junk-rated debt will likely have a hard time tapping capital markets in 2020, increasing the odds for wave of defaults, according to a new report by Moody’s Investors Service.

“Despite our expectation of a generally low interest rate environment globally, such companies face greater risk because of continuing overproduction, depressed natural gas prices and widespread investor risk aversion toward the exploration and production sector,” said Moody’s analyst Sajjad Alam. (…)

EARNINGS WATCH

We now have 410 companies in, a 71% beat rate with a +5.1% surprise factor. Q4 earnings are now expected up 3.2% vs –0.3% on Jan. 1. Revenues are up 5.1% vs +4.1% on Jan. 1.

Q1’20 earnings are seen up 3.4%, much slower than the +6.3% of Jan. 1. Q2 forecasts are also trimmed, from +7.2% to +6.0%. Still, full year earnings are seen up 7.8% (vs +9.7% on Jan. 1), a sharp acceleration from +2.0% in 2019.

Pre-announcements remain generally positive compared to Q1’19 and Q4’19 but the all of the last 4 were negative…

Trailing EPS are now $164.59. The Rule of 20 P/E is 22.79.